<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recently, we determined several potential prognostic factors in vivo using hypoxic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells from <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Among them, expression of adrenomedullin (ADM) was an interesting target because it is highly induced by <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: To evaluate the prognostic impact of the expression of ADM, samples from a total of 373 CRC patients were analyzed by microarray (n = 222), and quantitative reverse-transcriptase polymerase chain reaction (n = 151) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: ADM was a novel independent prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p = 0.027) </plain></SENT>
<SENT sid="4" pm="."><plain>ADM expression correlated with <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor-1 A (p &lt; 0.0001) and vascular endothelial growth factor (p &lt; 0.0001) in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: ADM expression is a useful marker for predicting high risk of relapse and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> in patients who have undergone curative resection for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>